JeromeSFischerMD

Endocrinology • San Antonio, TX

Diabetes, Lipid Metabolism, Thyroid

Diabetes & Glandular Disease Clinic

Join to view full profile

Dr. Fischer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fischer's full profile

Already have an account?

Office
5107 Medical Dr
San Antonio, TX 78229
Phone+1 210-614-8612

Fax+1 210-615-1666

Education & Training

George Washington UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1982
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1977 - 1980
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1977 - 1978
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1977

Certifications & Licensure

NY State Medical License 1978 - Present
TX State Medical License 1983 - 2025
MD State Medical License 1981 - 1984
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACE) American Association of Clinical Endocrinology

Publications & Presentations

PubMed

2 citations
Diabetes Healthcare Professionals Use Multiple Continuous Glucose Monitoring Data Indicators to Assess Glucose Management.
Tong Sheng, Reid Offringa, David Kerr, Mark A. Clements, Jerome S. Fischer
Journal of Diabetes Science and Technology. 2020-03-01
15 citations
United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens.
Jerome S. Fischer, Steven V. Edelman, Sherwyn Schwartz
Journal of Diabetes Science and Technology. 2008-11-01
204 citations
Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
Irl B. Hirsch, Jill M. Abelseth, Bruce W. Bode, Jerome S Fischer, Francine R. Kaufman
Diabetes Technology & Therapeutics. 2008-08-21

Press Mentions

Pilot Shows Smartphone App and Population Management-Facilitated Type-2 Diabetes Management Can Significantly Improve Blood Glucose ControlOctober 29th, 2015

Other Languages

Spanish

External Links

Websitehttp://www.dgdclinic.com